| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| SOUTHWELL DAVID P | Director | C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY | /s/ Martin Wilson, as attorney-in-fact for David Southwell | 18 Jul 2025 | 0001251553 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RCKT | Common Stock | Award | $0 | +30,000 | +1807% | $0.000000 | 31,660 | 18 Jun 2025 | Direct | F1 |
| holding | RCKT | Common Stock | 113,124 | 18 Jun 2025 | By The David P. Southwell Irrevocable Trust Dtd 04/14/2024 |
| Id | Content |
|---|---|
| F1 | Represent restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026. |